Monte Rosa Therapeutics Inc (GLUE)
8.48
-0.15
(-1.74%)
USD |
NASDAQ |
Nov 14, 16:00
8.48
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Market Cap: 520.44M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 14, 2024 | 520.44M |
| November 13, 2024 | 529.65M |
| November 12, 2024 | 560.33M |
| November 11, 2024 | 614.34M |
| November 08, 2024 | 568.31M |
| November 07, 2024 | 584.88M |
| November 06, 2024 | 579.97M |
| November 05, 2024 | 574.45M |
| November 04, 2024 | 542.54M |
| November 01, 2024 | 546.22M |
| October 31, 2024 | 521.67M |
| October 30, 2024 | 565.86M |
| October 29, 2024 | 575.06M |
| October 28, 2024 | 581.81M |
| October 25, 2024 | 300.11M |
| October 24, 2024 | 298.89M |
| October 23, 2024 | 298.89M |
| October 22, 2024 | 325.89M |
| October 21, 2024 | 334.48M |
| October 18, 2024 | 338.78M |
| October 17, 2024 | 336.94M |
| October 16, 2024 | 337.55M |
| October 15, 2024 | 314.23M |
| October 14, 2024 | 301.95M |
| October 11, 2024 | 302.57M |
| Date | Value |
|---|---|
| October 10, 2024 | 297.04M |
| October 09, 2024 | 294.59M |
| October 08, 2024 | 306.86M |
| October 07, 2024 | 311.16M |
| October 04, 2024 | 312.39M |
| October 03, 2024 | 313.62M |
| October 02, 2024 | 330.80M |
| October 01, 2024 | 325.28M |
| September 30, 2024 | 325.28M |
| September 27, 2024 | 317.30M |
| September 26, 2024 | 328.96M |
| September 25, 2024 | 338.16M |
| September 24, 2024 | 349.21M |
| September 23, 2024 | 365.17M |
| September 20, 2024 | 397.70M |
| September 19, 2024 | 383.58M |
| September 18, 2024 | 365.17M |
| September 17, 2024 | 363.33M |
| September 16, 2024 | 344.92M |
| September 13, 2024 | 373.15M |
| September 12, 2024 | 365.78M |
| September 11, 2024 | 381.74M |
| September 10, 2024 | 390.33M |
| September 09, 2024 | 363.94M |
| September 06, 2024 | 349.21M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
125.16M
Minimum
Oct 25 2023
1.958B
Maximum
Sep 03 2021
486.05M
Average
361.94M
Median
Apr 12 2024
Market Cap Benchmarks
| Novartis AG | 206.72B |
| MEI Pharma Inc | 20.06M |
| Evoke Pharma Inc | 6.488M |
| Revance Therapeutics Inc | 452.13M |
| Vera Therapeutics Inc | 3.103B |
Market Cap Related Metrics
| Price to Book Value | 2.316 |
| Price | 8.48 |
| Earnings Yield | -26.42% |